These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 23330188)

  • 1. [Spasticity in children cerebral palsy: diagnosis and treatment strategies].
    Kurenkov AL; Batysheva TT; Vinogradov AV; Ziuziaeva EK
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7 Pt 2):24-8. PubMed ID: 23330188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to managing spasticity in children with cerebral palsy.
    Im D; McDonald CM
    West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic interventions for tone abnormalities in cerebral palsy.
    Tilton AH
    NeuroRx; 2006 Apr; 3(2):217-24. PubMed ID: 16554259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of spasticity in children with cerebral palsy].
    Matthews DJ; Balaban B
    Acta Orthop Traumatol Turc; 2009; 43(2):81-6. PubMed ID: 19448346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of spasticity in children with cerebral palsy.
    Tilton A
    Semin Pediatr Neurol; 2009 Jun; 16(2):82-9. PubMed ID: 19501336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of cerebral palsy with botulinum toxin: evaluation with gross motor function measure.
    Yang TF; Chan RC; Chuang TY; Liu TJ; Chiu JW
    J Formos Med Assoc; 1999 Dec; 98(12):832-6. PubMed ID: 10634023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic interventions for reducing spasticity in cerebral palsy.
    Patel DR; Soyode O
    Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of severe contractures might replace multilevel surgery in cerebral palsy: results of a population-based health care programme and new techniques to reduce spasticity.
    Hägglund G; Andersson S; Düppe H; Lauge-Pedersen H; Nordmark E; Westbom L
    J Pediatr Orthop B; 2005 Jul; 14(4):269-73. PubMed ID: 15931031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical treatment (non surgical) of spasticity in cerebral palsy].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):1-6. PubMed ID: 11988886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spasticity management: an overview.
    Goldstein EM
    J Child Neurol; 2001 Jan; 16(1):16-23. PubMed ID: 11225951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity.
    Agarwal S; Patel T; Shah N; Patel BM
    Biomed Pharmacother; 2017 Mar; 87():628-635. PubMed ID: 28086137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
    Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
    Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug treatments for spasticity.
    Yelnik AP; Simon O; Bensmail D; Chaleat-Valayer E; Decq P; Dehail P; Quentin V; Marque P; Parratte B; Pellas F; Rousseaux M; Trocello JM; Uzzan M; Dumarcet N;
    Ann Phys Rehabil Med; 2009 Dec; 52(10):746-56. PubMed ID: 19892619
    [No Abstract]   [Full Text] [Related]  

  • 14. The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.
    Pidcock FS
    J Pediatr; 2004 Aug; 145(2 Suppl):S33-5. PubMed ID: 15292885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spasticity and botulinum toxin in 2003. An update].
    Fève A
    Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety considerations in the use of botulinum toxins in children with cerebral palsy.
    Apkon SD; Cassidy D
    PM R; 2010 Apr; 2(4):282-4. PubMed ID: 20430330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of spasticity in children with cerebral palsy.
    Chung CY; Chen CL; Wong AM
    J Formos Med Assoc; 2011 Apr; 110(4):215-22. PubMed ID: 21540003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
    Fève A; Decq P; Filipetti P; Kéravel Y
    Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spasticity.
    Rush R; Kumbhare D
    CMAJ; 2015 Apr; 187(6):436. PubMed ID: 25404397
    [No Abstract]   [Full Text] [Related]  

  • 20. The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral palsy.
    Criswell SR; Crowner BE; Racette BA
    Neurosurg Focus; 2006 Aug; 21(2):e1. PubMed ID: 16918222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.